Literature DB >> 16110843

Protective effect of melatonin and omeprazole against alendronat-induced gastric damage.

Goksel Sener1, Figen Onuk Goren, Nefise B Ulusoy, Yasemin Ersoy, Serap Arbak, Gül Ayanoglu Dülger.   

Abstract

Alendronate causes serious gastrointestinal adverse effects. We aimed to investigate if free radicals have any role in the damage induced by alendronate and if melatonin or omeprazole is protective against this damage. Rats were administered 20 mg/kg alendronate by gavage for 4 days, either alone or following treatment with melatonin or omeprazole. On the last day, following drug administration, pilor ligation was performed, and 2 hr later rats were killed and stomachs were removed. Gastric acidity and tissue ulcer index values, lipid peroxidation, and myeloperoxidase and glutathione levels, as well as the histologic appearance of the stomach tissues, were determined. Chronic oral administration of alendronate induced significant gastric damage, increasing lipid peroxidation and myeloperoxidase activity, while tissue glutathione levels decreased. Treatment with omeprazole or melatonin prevented this damage as well as the changes in biochemical parameters, and melatonin appeared to be more efficient than omeprazole in protecting the mucosa. Intraperitoneal administration of alendronate did not cause much gastric irritation. Findings of the present study suggest that alendronate induces oxidative gastric damage by a local irritant effect and that melatonin and omeprazole are protective against this damage due to their antioxidant properties.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16110843     DOI: 10.1007/s10620-005-2869-1

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  35 in total

1.  A quantitative method for measuring spontaneous gastric secretion in the rat.

Authors:  H SHAY; D C SUN; M GRUENSTEIN
Journal:  Gastroenterology       Date:  1954-06       Impact factor: 22.682

2.  Effect of bisphosphonates on surface hydrophobicity and phosphatidylcholine concentration of rodent gastric mucosa.

Authors:  L M Lichtenberger; J J Romero; G W Gibson; M A Blank
Journal:  Dig Dis Sci       Date:  2000-09       Impact factor: 3.199

Review 3.  The role of inflammation in vascular diseases.

Authors:  G W Sullivan; I J Sarembock; J Linden
Journal:  J Leukoc Biol       Date:  2000-05       Impact factor: 4.962

Review 4.  Gastric toxicity and mucosal ulceration induced by oxygen-derived reactive species: protection by melatonin.

Authors:  D Bandyopadhyay; K Biswas; M Bhattacharyya; R J Reiter; R K Banerjee
Journal:  Curr Mol Med       Date:  2001-09       Impact factor: 2.222

5.  Protective effect of famotidine, omeprazole, and melatonin against acetylsalicylic acid-induced gastric damage in rats.

Authors:  G Sener-Muratoğlu; K Paskaloğlu; S Arbak; C Hürdağ; G Ayanoğlu-Dülger
Journal:  Dig Dis Sci       Date:  2001-02       Impact factor: 3.199

6.  Melatonin protects against gastric ulceration and increases the efficacy of ranitidine and omeprazole in reducing gastric damage.

Authors:  Debashis Bandyopadhyay; Arun Bandyopadhyay; Pratap K Das; Russel J Reiter
Journal:  J Pineal Res       Date:  2002-08       Impact factor: 13.007

7.  Effects of alendronate on gastric and duodenal mucosa.

Authors:  F Lanza; M F Rack; T J Simon; A Lombardi; R Reyes; S Suryawanshi
Journal:  Am J Gastroenterol       Date:  1998-05       Impact factor: 10.864

Review 8.  Esophagitis associated with the use of alendronate.

Authors:  P C de Groen; D F Lubbe; L J Hirsch; A Daifotis; W Stephenson; D Freedholm; S Pryor-Tillotson; M J Seleznick; H Pinkas; K K Wang
Journal:  N Engl J Med       Date:  1996-10-03       Impact factor: 91.245

Review 9.  Melatonin: reducing the toxicity and increasing the efficacy of drugs.

Authors:  Russel J Reiter; Dun-Xian Tan; Rosa M Sainz; Juan C Mayo; Silvia Lopez-Burillo
Journal:  J Pharm Pharmacol       Date:  2002-10       Impact factor: 3.765

10.  Assessment of myeloperoxidase activity in whole rat kidney.

Authors:  L M Hillegass; D E Griswold; B Brickson; C Albrightson-Winslow
Journal:  J Pharmacol Methods       Date:  1990-12
View more
  4 in total

1.  A case-control study of the risk of upper gastrointestinal mucosal injuries in patients prescribed concurrent NSAIDs and antithrombotic drugs based on data from the Japanese national claims database of 13 million accumulated patients.

Authors:  Nobuyuki Sugisaki; Ryuichi Iwakiri; Nanae Tsuruoka; Yasuhisa Sakata; Ryo Shimoda; Shun Fujimoto; Yuichiro Eguchi; Kazuma Fujimoto
Journal:  J Gastroenterol       Date:  2018-06-12       Impact factor: 7.527

Review 2.  Reactive oxygen species and the hypomotility of the gall bladder as targets for the treatment of gallstones with melatonin: a review.

Authors:  Sreedevi Koppisetti; Bharat Jenigiri; M Pilar Terron; Sandra Tengattini; Hiroshi Tamura; Luis J Flores; Dun-Xian Tan; Russel J Reiter
Journal:  Dig Dis Sci       Date:  2008-03-13       Impact factor: 3.199

3.  Protective Effects of Simvastatin Against Alendronate-Induced Gastric Mucosal Injury in Rats.

Authors:  Nathalia S Carvalho; Mônica M Silva; Renan O Silva; Lucas A D Nicolau; Thiago S L Araújo; Douglas S Costa; Nayara A Sousa; Luan K M Souza; Pedro M G Soares; Jand Venes R Medeiros
Journal:  Dig Dis Sci       Date:  2015-09-24       Impact factor: 3.199

Review 4.  Clodronic acid formulations available in Europe and their use in osteoporosis: a review.

Authors:  Bruno Frediani; Luca Cavalieri; Giovanni Cremonesi
Journal:  Clin Drug Investig       Date:  2009       Impact factor: 2.859

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.